- Kingscrowd Newsletter
- Posts
- Tap the Market: How Breweries are Funding with Reg CF
Tap the Market: How Breweries are Funding with Reg CF
Brewing loyalty and funding growth—Reg CF is fueling the next wave of indie beer.
CHART OF THE WEEK 📈
By Teddy Lyons | Read
In honor of National Beer Day, this week’s Chart of the Week explores how independent breweries have embraced Reg CF to fuel expansion, build brand loyalty, and stay true to their communities. Curious how much they’ve raised and why this funding model is such a great fit? Let’s dive into the data.
Want the full story and takeaways? To view the complete analysis, read the full article for free on Kingscrowd HERE.
Have a suggestion for a data story you’d like us to look into? Submit by replying to this email
INVESTMENT ROUNDTABLE
In this week’s Kingscrowd Podcast, we analyze why Reg CF investments spiked dramatically in March and explore investor behavior amid public market volatility. Plus, discover Rise Robotics—a company transforming hydraulics with innovative electrification technology.
Kingscrowd at the SEC: Shaping the Future of Reg CF
Kingscrowd’s Brian Belley on a panel with the SEC in Washington, D.C.
Kingscrowd’s VP of Product, Brian Belley, recently joined the SEC’s 44th Annual Small Business Forum in D.C. to advocate for critical Regulation Crowdfunding reforms. Representing both Kingscrowd and the Crowdfunding Professional Association, Brian laid out a bold case for a dual-track regulatory approach—one that better supports both local businesses and high-growth startups.
PITCH REVIEW 💸
By Léa Bouhelier-Gautreau \ Deal Report
Brief: SorbiForce is developing a sustainable, non-metal battery that replaces lithium and cobalt with eco-friendly materials like carbon, iodine, and salts, using water as an electrolyte. Designed for large-scale energy users such as solar farms and industrial sites, its modular battery system is housed in standard shipping containers for easy deployment and integration. Founded in 2022 with R&D roots in Ukraine, SorbiForce has progressed from lab samples to working 2 kWh prototypes and is now raising funds to launch pilot production, gain certifications, and expand its team.
Léa’s Take: It’s no secret: lithium-ion batteries need to be disrupted. They pose serious fire risks and environmental challenges, but until now, they've remained the cheapest option on the market. Many startups are working on alternatives that could become cost-competitive—at least in the long run. And now, something just gave them a push: tariffs.
Roughly 80% of lithium-ion batteries are imported from China. If the new 145% tariff holds, U.S.-made energy storage solutions will gain a competitive advantage on price. That’s why this might be the right moment to look at SorbiForce. The company has developed a compostable battery that will be 100% U.S.-manufacturable, with stable, predictable pricing.
If you, like me, believe a solid product isn’t enough without market traction, you’re not wrong. SorbiForce has already secured nearly $200 million in signed letters of intent. So, what’s the catch? The company was founded in Western Ukraine by a remarkably resilient team and now needs a few million dollars to kick off production in Arizona. There’s space for SorbiForce in the crowded battery storage market—because this isn’t a winner-takes-all game. The momentum is there for SorbiForce and other sustainable, U.S.-based battery challengers. But even here, money is king.
STAFF PICKS 🌶️
By Léa Bouhelier-Gautreau
Marketplaces are a tough business to run. They require constant infusions of capital to grow simultaneously the demand and supply sides. Runner City is a peer-to-peer marketplace to run errands: think Task Rabbit but with lower fees. While I don't know if charging less fees than the big platforms will be sustainable in the long run, I'm happy to see that the company's valuation is low enough to partially compensate for the risk.
Having cancer is a terrible experience for anyone, and its treatment options are so invasive that they drastically lower patients' quality of life. SenoGuard is trying to make breast cancer treatment less toxic, more affordable, and more easily available to women with little to no sick leave. The company is now raising funds to access its $1 million NSF grant and test its final design for FDA submission. Like with many healthcare deals, the investment risks are high, but the reward, both financial and social, match them.
nView medical is a fairly valued 3D imaging medical startup with FDA clearance. This combination is rare, especially when startups like nView, already have traction and revenue. It may not be the only company innovating in the surgery imagine space, but it deserves to attract a bit of investors' attention.
What did you think of this newsletter? |
Enjoyed this newsletter? Forward it to an investing-minded friend and have them signup here.